Nat Rev Cardiol
-
Publication Venue For
- Cognitive dysfunction in atrial fibrillation.. 15:744-756. 2018
- The epicardium as a hub for heart regeneration.. 15:631-647. 2018
- Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention.. 15:480-496. 2018
- Revascularization in stable coronary disease: evidence and uncertainties.. 15:408-419. 2018
- Reversal agents for non-vitamin K antagonist oral anticoagulants.. 15:273-281. 2018
- Arrhythmias in 2016: Arrhythmia treatment - evidence catching up with technology.. 14:75-76. 2017
- Antiplatelet therapy: What have we learned from the ANTARCTIC trial?. 13:639-640. 2016
- Arterial access and arteriotomy site closure devices.. 13:641-650. 2016
- Enhancing the value of clinical trials: the role of data sharing.. 13:629-630. 2016
- Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy.. 13:549-559. 2016
- Acute coronary syndromes in women and men.. 13:471-480. 2016
- Assessing quality-of-life outcomes in cardiovascular clinical research.. 13:286-308. 2016
- Pathophysiology and clinical evaluation of acute heart failure.. 13:28-35. 2016
- Biomarkers: Troponin testing--risk stratification to stratified medicine.. 12:625-626. 2015
- Registry-based randomized clinical trials--a new clinical trial paradigm.. 12:312-316. 2015
- Acute coronary syndromes: Treatment for low-risk patients with STEMI--challenges remain.. 11:440-442. 2014
- Acute coronary syndromes: Right direction--moving proximally in timing of STEMI care.. 11:320-321. 2014
- Acute coronary syndromes. STREAMlining care for patients with STEMI.. 10:304-306. 2013
- Surgery. Translating trials to clinical practice in cardiac surgery.. 10:306-307. 2013
- Acute coronary syndromes: Blood transfusion in patients with acute MI and anaemia.. 10:186-187. 2013
- The disconnect between phase II and phase III trials of drugs for heart failure.. 10:85-97. 2013
- Novel biomarkers in chronic heart failure.. 9:347-359. 2012
- Acute coronary syndromes. Challenging accepted post-MI serum potassium targets.. 9:259-260. 2012
- Oral factor Xa inhibitors for the long-term management of ACS.. 9:392-401. 2012
- The pharmacogenetics of antiplatelet agents: towards personalized therapy?. 8:560-571. 2011
- Assessment of oral antithrombotic therapy by platelet function testing.. 8:572-579. 2011
- Heart failure in 2010: one step forward, two steps back.. 8:72-73. 2011
- Percutaneous coronary intervention in the elderly.. 8:79-90. 2011
- Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy.. 8:7-8. 2011
- Risk factors: Anxiety and risk of cardiac events.. 7:606-608. 2010
- Molecular imaging: T2-weighted CMR of the area at risk--a risky business?. 7:547-549. 2010
- Pharmacotherapy: Intracoronary streptokinase in acute myocardial infarction.. 7:67-69. 2010